A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: implications for radiation dose escalation in carcinoma of the pancreas
Anurag K Singh, Ryan M Tierney, Daniel A Low, Parag J Parikh, Robert J Myerson, Joseph O Deasy, Catherine S Wu, Gisele C Pereira, Sasha H Wahab, Sasa Mutic, Perry W Grigsby, Andrew J Hope, Anurag K Singh, Ryan M Tierney, Daniel A Low, Parag J Parikh, Robert J Myerson, Joseph O Deasy, Catherine S Wu, Gisele C Pereira, Sasha H Wahab, Sasa Mutic, Perry W Grigsby, Andrew J Hope
Abstract
Purpose: As a foundation for a dose escalation trial, we sought to characterize duodenal and non-duodenal small bowel organ motion between fractions of pancreatic radiation therapy.
Patients and methods: Nine patients (4 women, 5 men) undergoing radiation therapy were enrolled in this prospective study. The patients had up to four weekly CT scans performed during their course of radiation therapy. Pancreas, duodenum and non-duodenal small bowel were then contoured for each CT scan. On the initial scan, a four-field plan was generated to fully cover the pancreas. This plan was registered to each subsequent CT scan. Dose-volume histogram (DVH) analyses were performed for the duodenum, non-duodenal small bowel, large bowel, and pancreas.
Results: With significant individual variation, the volume of duodenum receiving at least 80% of the prescribed dose was consistently greater than the remaining small bowel. In the patient with the largest inter-fraction variation, the fractional volume of non-duodenal small bowel irradiated to at least the 80% isodose line ranged from 1% to 20%. In the patient with the largest inter-fraction variation, the fractional volume of duodenum irradiated to at least the 80% isodose line ranged from 30% to 100%.
Conclusion: The volume of small bowel irradiated during four-field pancreatic radiation therapy changes substantially between fractions. This suggests dose escalation may be possible. However, dose limits to the duodenum should be stricter than for other segments of small bowel.
Figures
References
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.
- Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001;50:265–278. doi: 10.1016/S0360-3016(01)01453-5.
- Horst E, Micke O, Moustakis C, Schuck A, Schafer U, Willich NA. Conformal therapy for pancreatic cancer: variation of organ position due to gastrointestinal distention--implications for treatment planning. Radiology. 2002;222:681–686.
- Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:1389–1399. doi: 10.1016/S0360-3016(01)02789-4.
- Ahn YC, Shimizu S, Shirato H, Hashimoto T, Osaka Y, Zhang XQ, Abe T, Hosokawa M, Miyasaka K. Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer. Yonsei Med J. 2004;45:584–590.
- Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30:979–985. doi: 10.1118/1.1568978.
- Kimura W. Surgical anatomy of the pancreas for limited resection. J Hepatobiliary Pancreat Surg. 2000;7:473–479. doi: 10.1007/s005340070017.
- Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws EA, Phoa SS, Gonzalez Gonzalez D. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer. 2000;89:2222–2229. doi: 10.1002/1097-0142(20001201)89:11<2222::AID-CNCR10>;2-V.
Source: PubMed